0917 EMB 7a ET Thu Finch series D
BioCentury & Getty Images


Awaiting dialogue with FDA on GI program, microbiome play Finch looks to autism, HBV with new $90M round

Sep 17, 2020 | 3:22 PM GMT

With one pivotal readout in Clostridium difficile already achieved, microbiome company Finch has tapped investors for a $90 million series D

Read the full 566 word article

How to gain access

Continue reading with a
two-week free trial.